Print

MB66-01

Phase 1, Single Center Study to Assess the Safety of MB66, a Combined Anti-HIV (VRC01-N) and Anti-HSV (HSV8-N) Monoclonal Antibody Film for Vaginal Application as Microbicide

Trial Details:

I Ongoing
Leaf Bio; National Institute of Allergy and Infectious Diseases (NIAID) January 01, 2016
MB66 VRC01 antibody and HSV8 antibody
MB66 Passive Immunization
USA 43
NCT02579083
https://clinicaltrials.gov/show/NCT02579083